<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Toxicol Sci</journal-id>
<journal-id journal-id-type="iso-abbrev">Toxicol. Sci</journal-id>
<journal-id journal-id-type="publisher-id">toxsci</journal-id>
<journal-title-group>
<journal-title>Toxicological Sciences</journal-title>
</journal-title-group>
<issn pub-type="ppub">1096-6080</issn>
<issn pub-type="epub">1096-0929</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30796839</article-id>
<article-id pub-id-type="pmc">6542340</article-id>
<article-id pub-id-type="doi">10.1093/toxsci/kfz054</article-id>
<article-id pub-id-type="publisher-id">kfz054</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pbde Toxicity in Breast Cancer Cell Models</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Molecular Mechanisms of Polybrominated Diphenyl Ethers (BDE-47, BDE-100, and BDE-153) in Human Breast Cancer Cells and Patient-Derived Xenografts</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kanaya</surname>
<given-names>Noriko</given-names>
</name>
<xref ref-type="aff" rid="kfz054-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bernal</surname>
<given-names>Lauren</given-names>
</name>
<xref ref-type="aff" rid="kfz054-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chang</surname>
<given-names>Gregory</given-names>
</name>
<xref ref-type="aff" rid="kfz054-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yamamoto</surname>
<given-names>Takuro</given-names>
</name>
<xref ref-type="aff" rid="kfz054-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nguyen</surname>
<given-names>Duc</given-names>
</name>
<xref ref-type="aff" rid="kfz054-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yuan-Zhong</given-names>
</name>
<xref ref-type="aff" rid="kfz054-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>June-Soo</given-names>
</name>
<xref ref-type="aff" rid="kfz054-aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-1827-4486</contrib-id>
<name>
<surname>Warden</surname>
<given-names>Charles</given-names>
</name>
<xref ref-type="aff" rid="kfz054-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Jinhui</given-names>
</name>
<xref ref-type="aff" rid="kfz054-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wu</surname>
<given-names>Xiwei</given-names>
</name>
<xref ref-type="aff" rid="kfz054-aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Synold</surname>
<given-names>Timothy</given-names>
</name>
<xref ref-type="aff" rid="kfz054-aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rakoff</surname>
<given-names>Michele</given-names>
</name>
<xref ref-type="aff" rid="kfz054-aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Neuhausen</surname>
<given-names>Susan L</given-names>
</name>
<xref ref-type="aff" rid="kfz054-aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Shiuan</given-names>
</name>
<xref ref-type="aff" rid="kfz054-aff1">1</xref>
<xref ref-type="corresp" rid="kfz054-cor1"></xref>
<!--<email>schen@coh.org</email>-->
</contrib>
</contrib-group>
<aff id="kfz054-aff1"><label>1</label>Department of Cancer Biology, Beckman Research Institute of City of Hope, Duarte, California 91010</aff>
<aff id="kfz054-aff2"><label>2</label>Environmental Chemistry Laboratory, Department of Toxic Substances Control, Berkeley, California 94710</aff>
<aff id="kfz054-aff3"><label>3</label>Integrative Genomics Core, Beckman Research Institute of City of Hope, Duarte, California 91010</aff>
<aff id="kfz054-aff4"><label>4</label>Breast Cancer Care &amp; Research Fund, Los Angeles, California 90036</aff>
<aff id="kfz054-aff5"><label>5</label>Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California 91010</aff>
<author-notes>
<corresp id="kfz054-cor1">To whom correspondence should be addressed at Department of Cancer Biology, Beckman Research Institute of the City of Hope, 1500 East Duarte Road, Duarte, CA 91010. Fax: (626) 301-8972. E-mail: <email>schen@coh.org</email>.</corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date iso-8601-date="2019-02-23" pub-type="epub">
<day>23</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>6</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>169</volume>
<issue>2</issue>
<fpage>380</fpage>
<lpage>398</lpage>
<permissions>
<copyright-statement>© The Author(s) 2019. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="publisher-standard" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="kfz054.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Polybrominated diphenyl ethers (PBDEs) have been used as flame retardants in household materials. Their environmental persistence has led to continuous human exposure and significant tissue levels. Three PBDE congeners (BDE-47, BDE-100, and BDE-153) have been frequently detected in human serum. Although these compounds appear to possess endocrine disrupting activity, studies are largely missing to determine the biological mechanisms of PBDEs in breast cancer cells. Here, we assessed PBDE bioactivities with three complementary strategies: receptor binding/activity assays; nonbiased RNA-sequencing analysis using an estrogen-dependent breast cancer cell line MCF-7aroERE; and <italic>in vivo</italic> assessments using patient-derived xenograft (PDX) models of human breast cancer. According to the results from <italic>in vitro</italic> experiments, the PBDE congeners regulate distinct nuclear receptor signaling pathways. BDE-47 acts as a weak agonist of both estrogen receptor α (ERα) and estrogen-related receptor α (ERRα); it could stimulate proliferation of MCF-7aroERE and induced expression of ER-regulated genes (including cell cycle genes). BDE-153 was found to act as a weak antagonist of ERα. BDE-100 could act as (1) an agonist of aryl hydrocarbon receptor (AhR), inducing expression of CYP1A1 and CYP1B1 and (2) as a very weak agonist/antagonist of ERα. <italic>In vivo</italic>, a mixture of the three congeners with ratios detected in human serum was tested in an ER+ PDX model. The mixture exhibited estrogenic activity through apoptosis/cell cycle regulation and increased the expression of a proliferation marker, Ki-67. These results advance our understanding of the mechanisms of PBDE exposure in breast cancer cells.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>breast cancer</kwd>
<kwd>PBDE</kwd>
<kwd>ER</kwd>
<kwd>PR</kwd>
<kwd>ERR</kwd>
<kwd>AhR</kwd>
<kwd>ER+</kwd>
<kwd>PDX</kwd>
</kwd-group>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Breast Cancer and Environmental Research Program</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">NIH</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>U01ES026137-01</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Cancer Institute of the National Institutes of Health</named-content>
</funding-source>
<award-id>P30CA033572</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="19"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>